PET for radiation treatment planning of brain tumours

Radiotherapy and Oncology

Volumn 96, Issue 3, 2010, Pages 325-327

  Grosu, Anca L ^a   Weber, Wolfgang A ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Brain tumours; PET; Radiation treatment planning

Indexed keywords

3' FLUOROTHYMIDINE F 18; METHIONINE; PEPTIDE;

ANGIOGENESIS; BRAIN TUMOR; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CELL HYPOXIA; GLIOMA; HUMAN; MENINGIOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SENSITIVITY AND SPECIFICITY; TREATMENT PLANNING; TUMOR VOLUME;

BRAIN NEOPLASMS; HUMANS; POSITRON-EMISSION TOMOGRAPHY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED;

EID: 77956188425     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2010.08.001     Document Type: Review

References (22)

1. D. Brandsma, L. Stalpers, and W. Taal Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas Lancet Oncol 9 2008 453 461
2. K.J. Langen, M. Jarosch, and H. Muhlensiepen Comparison of fluorotyrosines and methionine uptake in F98 rat gliomas Nucl Med Biol 30 2003 501 508
3. W.A. Weber, H.J. Wester, and A.L. Grosu O-2(18F)Fluorethyl-l-tyrosine and l-(methyl-11C)-methionine uptake in brain tumors: initial results of a comparative study Eur J Nucl Med 27 2000 542 549
4. Grosu AL, Weber WA, Riedl E et al. An interindividual comparison of O-(2-[18F]Fluoroethyl)-l-tyrosine (FET) and l-[methyl-11C]methionine (MET) PET in patients with brain gliomas and metastases. Int J Radiat Oncol Biol Phys 2010; doi:10.1016/j.ijrobp.2010.07.022.
5. A.L. Grosu, W.A. Weber, and H.J. Feldmann First experience with I-123-alpha-methyl-tyrosine SPECT in the 3-D radiation treatment planning of brain gliomas Int J Rad Oncol Biol Phys 47 2000 517 527
6. W.A. Weber, S. Dick, and G. Reidl Correlation between postoperative 3-(123I)-Iodo-l-alpha-methyltyrosine uptake and survival in patients with gliomas J Nucl Med 42 2001 1144 1150
7. A.L. Grosu, H.J. Feldmann, and S. Dick Implications of IMT-SPECT for postoperative radiation treatment planning in patients with gliomas Int J Rad Oncol Biol Phys 54 2002 842 854
8. A.L. Grosu, R. Lachner, and N. Wiedenmann Validation of a method for automatic fusion of CT- and C11-methionine-PET datasets of the brain for stereotactic radiotherapy using a LINAC. First clinical experience Int J Rad Oncol Biol Phys 56 2003 1450 1463
9. A.L. Grosu, A.W. Weber, and E. Riedel l-(Methyl-11C) methionine positron emissions tomography for target delineation in resected high grade gliomas before radiation therapy Int J Rad Oncol Biol Phys 63 2005 64 74
10. I.H. Lee, M. Piert, and D. Gomez-Hassan Association of 11C-methionine PET uptake with the site of failure after concurrent temozolomide and radiation for primary glioblastoma multiforme Int J Rad Oncol Biol Phys 73 2009 479 485
11. D.C. Weber, N. Casanova, and T. Zilli Recurrence pattern after [(18)F]fluoroethyltyrosine-positron emission tomography-guided radiotherapy for high-grade glioma: a prospective study Radiother Oncol 93 2009 586 592
12. A.L. Grosu, W.A. Weber, and M. Franz Re-Irradiation of recurrent high grade gliomas using amino-acids-PET(SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy Int J Rad Oncol Biol Phys 63 2005 511 519
13. W.A. Weber, A.L. Grosu, and J. Czernin Technology insight: advances in molecular imaging and an appraisal of PET/CT scanning Nat Clin Pract Oncol 5 2008 160 170
14. M.W. Gross, W.A. Weber, and H.J. Feldmann The value of F-18-fluorodeoxyglucose PET for the 3-D radiation treatment planning of malignant gliomas Int J Radiat Oncol Biol Phys 41 1998 989 995
15. A.L. Grosu, W.A. Weber, and S. Astner 11C-Methionine PET improves the target volume delineation of meningiomas treated with stereotactic fractionated radiotherapy Int J Rad Oncol Biol Phys 66 2006 339 344
16. S.T. Astner, M. Dobrei-Ciuchendea, and M. Essler Effect of 11C-methionine-positron emission tomography on gross tumor volume delineation in stereotactic radiotherapy of skull base meningiomas Int J Radiat Oncol Biol Phys. 72 2008 1161 1167
17. S. Milker-Zabel, A. Zabel-du Bois, and M. Henze Improved target volume definition for fractionated stereotactic radiotherapy in patients with intracranial meningiomas by correlation of CT, MRI, and [68Ga]-DOTATOC-PET Int J Radiat Oncol Biol Phys 65 2006 222 227
18. 68Ga]- DOTATOC-PET/CT for meningioma IMRT treatment planning Radiat Oncol 4 2009 56
19. S.T. Astner, R.A. Bundschuh, and A.J. Beer Assessment of tumor volumes in skull base glomus tumors using Gluc-Lys[(18)F]-TOCA positron emission tomography Int J Radiat Oncol Biol Phys 73 2009 1135 1140
20. R. Ullrich, H. Backes, and H. Li Glioma proliferation as assessed by 3'-fluoro-3'-deoxy-l-thymidine positron emission tomography in patients with newly diagnosed high-grade glioma Clin Cancer Res 14 2008 2049 2055
21. P.E. Valk, C.A. Mathis, and M.D. Prados Hypoxia in human gliomas: demonstration by PET with fluorine-18-fluoromisonidazole J Nucl Med 33 1992 2133 2137
22. A.J. Beer, A.L. Grosu, and J. Carlsen Feasibility of (18F)Galacto-RGD PET for imaging of αvβ3 expression on noevasculature in patients with squamous cell carcinoma of head and neck Clin Cancer Res 13 2007 6610 6616